Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Early ivabradine addition to beta-blockers in hospitalized HFrEF may affect HR and outcomes; hypothesis-generating and requires RCT confirmation.
Francisco Hidalgo (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: